Healthcare Global Enterprises Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 22,350,000 (75%) | — | ₹48,723 Cr |
| NII (HNI) | — | 4,470,000 (15%) | — | ₹9,745 Cr |
| Retail | — | 2,980,000 (10%) | — | ₹6,496 Cr |
| Σ Total | — | 29,800,000 (100%) | — | ₹649,640 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 65 | ₹14,170 |
| Retail (Max) | 13 | 845 | ₹184,210 |
| S-HNI (Min) | 14 | 910 | ₹198,380 |
| B-HNI (Min) | 67 | 4,355 | ₹949,390 |
Financial Statements Amount In Crore
| Metric | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 |
|---|---|---|---|
| Revenue | 424 | 353 | 294 |
| Profit After Tax | 2 | 40 | 7 |
| Total Assets | 690 | 614 | 644 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Purchase of medical equipment – 42.21
- 2 Investment in IT software, services and hardware – 30.19
- 3 Pre-payment of debt – 147.05
- 4 General corporate purposes – 19.77
Company Overview
Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of speciality healthcare in India focused on cancer and fertility.
HCG operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. HCG also operates fertility centres under the 'Milann' brand.
As of December 31, 2015, HCG network consisted of 14 comprehensive cancer centres, including centre of excellence in Bengaluru, three freestanding diagnostic centres and one day care chemotherapy centre across India.
HCG acquired 50.10% equity in BACC Healthcare in 2013 which operates fertility centres under the Milann brand, through itself and its wholly-owned subsidiary, DKR Healthcare. HCG now operate four Milann fertility centres in Bengaluru. BACC Healthcare is led by a team of qualified and experienced fertility specialists. Its founder, Dr. Kamini Rao has a successful track record of over 25 years of providing fertility treatments. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment.
Under Triesta brand, HCG provide clinical reference laboratory services in India with a specialisation in oncology, including molecular diagnostic services and genomic testing. Triesta central reference laboratory is located in centre of excellence in Bengaluru.
Strengths of the Company:
1. Largest provider of cancer care in India with a proven track record
2. High quality cancer care provided at a competitive price
3. Entry into high potential fertility business
4. Strong management team with successful track record
5. Highly skilled specialist physicians
6. 'hub and spoke' business model and partnership arrangements